Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes

Diabetes

Volumn 62, Issue 9, 2013, Pages 3268-3274

  Orešič, Matej ^a   Gopalacharyulu, Peddinti ^a   Mykkänen, Juha ^b,c   Lietzen, Niina ^a   Mäkinen, Marjaana ^b,c   Nygren, Heli ^a   Simell, Satu ^b,c   Simell, Ville ^b,c   Hyöty, Heikki ^d,e   Veijola, Riitta ^f   Ilonen, Jorma ^b,g   Sysi Aho, Marko ^a   Knip, Mikael ^h,i,j,k   Hyötyläinen, Tuulia ^a   Simell, Olli ^b,c  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c HOSPITAL DISTRICT OF SOUTHWEST FINLAND   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e PIRKANMAA HOSPITAL DISTRICT   (Finland)

^f UNIVERSITY OF OULU   (Finland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^j TAMPERE UNIVERSITY HOSPITAL   (Finland)

^k FOLKHÄLSAN RESEARCH CENTER   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DQB1 ANTIGEN; LIPIDOME; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SPHINGOMYELIN; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN;

ARTICLE; AUTOIMMUNITY; BIRTH WEIGHT; CONTROLLED STUDY; CORD SERUM; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; GESTATIONAL AGE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LIPID COMPOSITION; LIPIDOMICS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UMBILICAL CORD; ADOLESCENT; CHILD; FETUS BLOOD; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; PANCREAS ISLET; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FETAL BLOOD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ BETA-CHAINS; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; PHOSPHOLIPIDS; PROSPECTIVE STUDIES;

EID: 84883230213     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0159     Document Type: Article

References (37)

1. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-920
2. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033
3. Knip M, Virtanen SM, Seppä K, et al.; Finnish TRIGR Study Group. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 2010;363:1900-1908
4. Achenbach P, Bonifacio E, Koczwara K, Ziegler A-G. Natural history of type 1 diabetes. Diabetes 2005;54(Suppl. 2):S25-S31
5. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008; 359:61-73
6. Dahlquist GG, Patterson C, Soltesz G. Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 1999;22:1698-1702
7. Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Åkerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005;54 (Suppl. 2):S125-S136
8. Koren O, Goodrich JK, Cullender TC, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012;150:470-480
9. Illig T, Gieger C, Zhai G, et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010;42:137-141
10. Velagapudi VR, Hezaveh R, Reigstad CS, et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 2010;51:1101-1112
11. Oresic M, Simell S, Sysi-Aho M, et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 2008;205:2975-2984
12. Pflueger M, Seppänen-Laakso T, Suortti T, et al. Age-and islet autoim-munity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes 2011;60:2740-2747
13. Oresic M, Hänninen VA, Vidal-Puig A. Lipidomics: a new window to biomedical frontiers. Trends Biotechnol 2008;26:647-652
14. Kupila A, Muona P, Simell T, et al.; Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001;44:290-297
15. Nejentsev S, Sjöroos M, Soukka T, et al. Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 1999;16:985-992
16. Parikka V, Näntö-Salonen K, Saarinen M, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 2012; 55:1926-1936
17. Siljander HT, Simell S, Hekkala A, et al. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009;58:2835-2842
18. Ilonen J, Reijonen H, Herva E, et al. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1996; 19:795-800
19. Nygren H, Seppänen-Laakso T, Castillo S, Hyötyläinen T, Oresic M. Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. Methods Mol Biol 2011;708:247-257
20. Pluskal T, Castillo S, Villar-Briones A, Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 2010;11:395
21. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2012
22. Fraley C, Raftery AE. Model-based methods of classification: Using the mclust software in chemometrics. J Stat Softw 2007;18:i06
23. Venables WN, Ripley BD. Modern Applied Statistics With S. New York, Springer Verlag, 2002
24. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997;16: 965-980
25. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005;21:3940-3941
26. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12:77
27. Mason SJ, Graham NE. Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: Statistical significance and interpretation. Q J R Meteorol Soc 2002;128:2145-2166
28. Hoving EB, van Beusekom CM, Nijeboer HJ, Muskiet FA. Gestational age dependency of essential fatty acids in cord plasma cholesterol esters and triglycerides. Pediatr Res 1994;35:461-469
29. Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001;73:807-814
30. Kulmala P, Savola K, Petersen JS, et al.; The Childhood Diabetes in Finland Study Group. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. J Clin Invest 1998;101: 327-336
31. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 2006;26:229-250
32. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 (Suppl.):245-254
33. Jiang X, Yan J, West AA, et al. Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. FASEB J 2012;26:3563-3574
34. Yan J, Jiang X, West AA, et al. Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans. Am J Clin Nutr 2012;95:1060-1071
35. Dumas M-E, Barton RH, Toye A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006;103:12511-12516
36. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003;348:2304-2312
37. Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med 2011;365:1812-1823